Correlating ADC Design Factors to Successful Efficacy & Safety Profiles in the Clinic
Time: 5:00 pm
day: Conference Day One pt 2
Details:
• Accurately characterising antibody, linker, payload, and overall conjugate contributions to ADC clinical performance
• Deep diving into ADC case studies to understand differentiated design impact on clinical safety and efficacy profiles
• Explaining favourable safety and efficacy profiles attributed to ADC designs against the same target or using different payloads
